InvestorBrandNetwork (IBN) Content Platform

Advisors Mortgage Group, based in Ocean Township, New Jersey, today announced that it has again made the Inc. 5000 2022 list of Fastest-Growing Private Companies. According to the update, this is the 11th year since 2003 that Advisors has received this recognition. “Being on this list is so incredible and something I never imagined 23 years ago when I started this company out of a 400-square-foot office,” said Steven Meyer, president of Advisors Mortgage Group. “Watching us grow into a robust company with over 400 employees nationwide is a testament to the hard work of those that helped me every step of the way. This company is a family, and we have created this together. I am humbled by everyone’s support and steadfast devotion to Advisors.”

To view the full press release, visit https://ibn.fm/bVNhm

About Advisors Mortgage Group

With big dreams and even more determination, Advisors Mortgage Group was founded in October 1999 by a single loan officer in a 400-square-foot office in Shrewsbury, New Jersey. In the years since its formation, Advisors has grown to serve not only the greater New Jersey area but also a vast portion of the United States. With branch offices up and down the East Coast and its corporate office in Ocean Township, New Jersey, Advisors Mortgage has established itself as a pillar of excellence in the mortgage industry. Its immense experience is Advisors Mortgage Group’s greatest asset and is the foundation of the success of the company and every Advisors branch and loan officer. In 2005, Advisors Mortgage Group was designated by the Federal Housing Authority as a Full Eagle FHA Underwriter. As a Full Eagle, Advisors has been able to expand its loan volume by approving loans, which a majority of the competition could not dream of. Advisors Mortgage Group has built a platform for a seamless and stress-free mortgage process for all of its customers, and it has that same mission throughout all of its offices. Advisors Mortgage Group understands that success cannot be attained without teamwork and communication, two of its most important strengths. For more information, visit the company’s website at https://AdvisorsMortgage.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space and soon-to-be leading the way in the over-the-counter (“OTC”) hearing technology space, announced that the FDA has released its Final Rule outlining the creation of a new category of OTC hearing aids. According to the OTC Hearing Aid Law, the hearing aids are designed for perceived mild to moderate hearing losses that are to be sold directly to consumers in retail stores, pharmacies and online. The hearing devices can be sold without a medical exam and without being fitted by a hearing healthcare professional. According to the announcement, 60 days after the final rule, which will be around Oct. 16, 2022, the law will be enacted, which means that consumers will be able to purchase OTC hearing aids right off the shelf directly from retailer, including big box retailers and pharmacy chains. “We have been waiting over five years for this day to come,” said InnerScope Hearing Technologies president and CEO Matthew Moore in the press release. “The true winners of the OTC Hearing Aid Law will be the consumers that have had to struggle and live with their hearing difficulties due to the high-cost hearing aids with the current Traditional Hearing Aid Delivery Model. First, I would like to thank Senator Elizabeth Warren (D-Mass) and Senator Chuck Grassley (R-Iowa) for their hard work and dedication in introducing this bipartisan Over-The-Counter Hearing Aid Act bill in 2016 and President Joe Biden for issuing an executive order to push the OTC Hearing Aid Law to be enacted finally. Second, the OTC Hearing Aid Law will open a new emerging market for hearing aids sales, potentially in the tens of billions of dollars. InnerScope, with its network of wholesale retailers, is ready when the OTC Hearing Aid Law is enacted to deliver its affordable OTC hearing aids to tens of millions of Americans.”

To view the full press release, visit https://ibn.fm/GGnSO

About InnerScope Hearing Technologies Inc.

InnerScope is a leading direct-to-consumer (“DTC”) manufacturer and distributor of FDA-registered hearing aids, hearing assistive devices, hearing health-related products and personal sound amplifier products (“PSAPs”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s hearing products and its business model break through the persistent barriers that prevent access to effective hearing solutions. The company’s recent acquisition of iHear Medical Inc., a DTC cloud-based hearing solution provider, gives InnerScope access to more than 40 patents and an FDA-registered manufacturing and R&D facility. InnerScope also acquired HearingAssist, an established leader in the direct-to-consumer hearing aid market with a customer base of more than 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation, AI smart devices, will allow InnerScope to better position itself in the DTC hearing-solutions market by selling advanced hearing products through Walmart and other major retailers. For more information, please visit www.INND.com. 

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital social casino games, is commemorating 12 years since the unveiling of its flagship title, DoubleDown Casino. The celebration includes free prizes and a DoubleDown Birthday Bash on Aug. 26 and 27, 2022, during which players are encouraged to complete slot quests to earn a reward based on how many quests they complete. DoubleDown Casino features a variety of slot machines and table games designed to provide a Las Vegas casino experience virtually on mobile and desktop platforms. This social casino game includes authentic Las Vegas slot machines developed by International Game Technology PLC (“IGT”). Between casino titles and exclusive original slots, DoubleDown has a catalog of more than 200 slots for players to choose from. “DoubleDown Casino was one of the first games of its kind when it debuted in 2010,” said DoubleDown CEO In Keuk Kim in the press release. “We are honored that DoubleDown Casino has remained one of the leading games in the social casino space for the past 12 years, and we are grateful to all our passionate players, to whom we owe our longstanding success.”

To view the full press release, visit https://ibn.fm/dhjpd

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multiformat interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. DDI’s flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. For more information about the company, visit www.DoubleDownInteractive.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• Cerberus Sentinel shares were listed on the Nasdaq in the first quarter of 2022
• The company joined the broad-market Russell 2000 Index in June 2022
• Cerberus Sentinel posted a 376% revenue CAGR for the years 2019 through 2021
• In 2021, 58% of the company’s revenue was recurring revenue from managed services contracts
• Cerberus Sentinel has completed 12 strategic acquisitions since October 2019
• The global managed security services market was valued at $22.45 billion in 2020 and is projected to reach $77.01 billion by 2030, growing at a CAGR of 12.8% through the forecast period

Cerberus Cyber Sentinel (NASDAQ: CISO) is an industry leader in cybersecurity and compliance services. The company leverages an integrated approach to reduce noise and bridge common silos that often limit the effectiveness of cybersecurity programs. Pulling disparate technologies, teams, and vendors together, Cerberus helps its clients enjoy a simpler and more successful journey to cyber resilience. Since 2019, Cerberus Sentinel has worked to rapidly expand by acquiring world-class cybersecurity and compliance businesses with top-tier talent who utilize the latest technology to create innovative protection solutions.

The Cerberus Sentinel workforce is comprised of cybersecurity experts spanning not only global geographies, but also specialties, industries, regulatory frameworks and…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), the digital face of the plant-based community, operating a one-stop shop for plant-based products, is releasing its unaudited monthly financial metrics for July 2022. According to the company, monthly gross revenue for July totaled C$1.2 million, an increase of 35% compared to C$910,000 in July 2021. The company attributed much of the increase to its Little West cold-pressed juice brand, which is seeing strong sell-through as consumers return to corporate offices, coffee shops and other locations where Little West products are readily available. Gross profit for the month was C$468,000, a 39% gross margin when compared to gross profit of C$318,000, or 35% gross margin, in July 2021. PlantX also provided an update regarding its previously announced management cease trade order (“MCTO”) issued by the British Columbia Securities Commission earlier this month. The MCTO was issued in connection with a delay in filing audited annual financial statements, management’s discussion and analysis and related officer certifications for the fiscal year ended March 31, 2022. PlantX is working diligently with its auditors and anticipates filing all required documents no later than Sept. 27, 2022. “As we see continued strong topline growth that, we are sharply focused on accelerating our path to profitability,” said PlantX CEO Lorne Rapkin in the press release. “We have refined our operations especially when it comes to staffing, optimizing our marketing activities and securing more favorable terms with suppliers. We are highly confident that these initiatives will translate into near-term further improvement in gross margins and a reduction in our net loss as our business continues to grow.”

To view the full press release, visit https://ibn.fm/aYUER

About PlantX Life Inc.

PlantX is committed to being the digital face of the plant-based community as well as the one-stop shop for everything plant based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering delivery service for meals and indoor plants, the company currently has plans underway to expand its product lines to include a juice and coffee company. PLTXF uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The company’s digital presence works to eliminate the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage company developing drugs for patients who have unmet medical conditions that require better treatment options to improve a patient’s survival and/or quality of life, has announced new board appointments. The company named Khoso Baluch and James Neal to its board of directors and appointed current board member Justin Yorke as board chair. According to the announcement, the new appointments are designed to position the company for anticipated milestone while ensuring adherence to high governance standards. Yorke is taking on the role of chair as the company focuses on three ongoing clinical trials and the development of all five of its pipeline products. Baluch has more than three decades of experience across global geographies in the biopharmaceutical industry. Most recently, he has served as an independent director of Poxel SA, a French publicly traded biotech company; he has also served as the board chair for Da Volterra, a French privately held company, and as CEO and board member at CorMedix Inc., a publicly traded U.S. pharmaceutical company in the United States. Neal has garnered more than two decades years of experience in forming and maximizing business and technology collaborations globally and in bringing novel products and technologies to market. Most recently, he has served as CEO and board chair of XOMA Corp. “I’m pleased to welcome both Khoso and Jim to our team,” said Processa Pharmaceuticals CEO Dr. David Young in the press release. “Their comprehensive backgrounds and experience in the biotech space, including licensing and commercialization, make them ideally suited to assist Processa at this stage of its evolution. I look forward to working with them and the rest of our board as we progress towards unlocking numerous value catalysts in our pipeline.”

To view the full press release, visit https://ibn.fm/sEfT7

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company uses these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active clinical pipeline programs include PCS6422 (“PCS6422”), a metastatic colorectal cancer and breast cancer program; PCS499 (“PCS499”), an ulcerative necrobiosis lipoidica program; and PCS12852 (“PCS12852”), a GI mobility and gastroparesis program. The members of the Processa development team have been involved with more than 30 drug approvals by the FDA, including drug products targeted to orphan disease conditions, and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com. 

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Sanwire (OTC: SNWR), a diversified company with a focus on technologies for the entertainment space, and its wholly owned subsidiary Intercept Music are reporting second-quarter results along with key corporate updates for Intercept Music. The company reported almost a 400% increase in month-over-month streaming, with 8.6 million streams reported in May. In addition, the report noted that Intercept has added 15 new proprietary marketing services, three advisors, four new partnerships and more than 50 new software updates throughout the quarter; one of the updates, royalty accounting, is one of the most comprehensive in the industry. According to the announcement, substantial marketing investments made in the first and second quarter have paid off, a “testament to the success of our marketing plans” and the company’s ability to push sales. A Software as a Service (SaaS) company, Intercept Music focuses exclusively on the independent music market, the fastest-growing sector of the music industry. “We’ve also added multiple artists and labels with outstanding talent,” said Intercept Music president Tod Turner in the press release. “Our marketing services are delivering real value, the average spend per new release has quadrupled to over $200, and our artists are winning awards and chart placement. . . . When you couple these new partnerships with the new marketing services, major artists and labels that have joined our family, and our catalog success with over 10,000 tracks, we’re firing on all cylinders.”

To view the full press release, visit https://ibn.fm/wgJ89

About Sanwire Corporation

Sanwire, a diversified company with a focus on technologies for the entertainment industry, has been involved in aggregating technologies for a number of years. Sanwire seeks opportunities in fragmented markets, where technology can be applied to consolidate services into a single platform of delivery. The company’s current focus is advanced entertainment technologies. For more information about the company, visit www.SanwireCorporation.com or www.InterceptMusic.com.

NOTE TO INVESTORS: The latest news and updates relating to SNWR are available in the company’s newsroom at https://ibn.fm/SNWR

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Exro Technologies (TSX: EXRO) (OTCQB: EXROF) is a leading clean technology company that has developed a new class of power electronics for electric motors and batteries. The company today announced its entry into an initial purchase order and multiyear master sales and service agreement to supply 1,500 Coil Drive System units to industry leading commercial electric vehicle company SEA Electric. The move is the latest in a series of commercial agreements with Exro’s development partners. “We are thrilled to announce another milestone in our partnership with SEA Electric,” said Sue Ozdemir, Exro CEO. “The project has faced delays as taking new tech to market is never linear, but this milestone is representative of SEA and Exro’s joint commitment to next-generation electrification in e-mobility. As we look to 2023 and beyond, our technology is de-risked, and momentum is building with customers like SEA who are looking for a differentiated technology that can improve performance while reducing cost. This latest announcement is a demonstration of Exro advancing to the next phase with a great partner and major industry player, and we are pleased to signal this unlocking of value to the market for our shareholders.”

To view the full press release, visit https://ibn.fm/vSfGR

About Exro Technologies Inc.

Exro is a clean technology company pioneering intelligent control solutions in power electronics to help solve the most challenging problems in electrification. Exro has developed a new class of control technology that expands the capabilities of electric motors, generators and batteries. Exro enables the application to achieve more with less energy consumed. Exro’s advanced motor control technology, the Coil Driver(TM), expands the capabilities of electric powertrains by enabling intelligent optimization for efficient energy consumption. Exro is working with many partners from all over the world to bring its technology to the electric mobility industries and beyond. For more information, visit the company’s website at www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the appointment of Jeff Newell to the company’s advisory board. Newell is expected to serve as a strategic resource to TRxADE as it continues to develop trade relationships in the industry. “We are thrilled to add industry experts like Mr. Newell to the advisory board and look forward to working with him to build stockholder value,” said Suren Ajjarapu, chairman of the board. “We are committed to fostering long-term growth and we believe we have the personnel resources and leadership in place to achieve this goal. We are excited about this new relationship and believe that the background and experience that Mr. Newell brings to TRxADE is going to be invaluable and that we will benefit from having access to Mr. Newell’s expertise.”

To view the full press release, visit https://ibn.fm/zeU4T

About TRxADE Health Inc.

TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company operates the TRxADE drug procurement marketplace serving a total of 13,815+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services and tele vet services. For more information on TRxADE Health, please visit the company’s IR website at investors.trxadehealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, is reporting its financial results for second quarter 2022, or the period ending June 30, 2022. Highlights of the report include record gross sales for the quarter with sales reaching $4.8 million, up 41% from the $3.4 million reported during the same period in 2021; the company pointed to increased sales of TapouT and e-commerce sales as key to the growth in sales. In addition, the report noted that SBEV had six new or expanded distribution/sales agreements with distributors or retailers during the quarter. Net loss for Q2 came in at $2.8 million in cash items and $3 million in non-cash items for a total of $5.8 million, with the company reporting total cash and cash equivalents of $4.2 million as of June 30, 2022. The company also announced that Circle K would be featuring its Copa di Vino brand in West Coast locations. The convenience store retail giant opted for the Copa di Vino rollout following a successful three-month-long test in California; the stores should begin selling the product in September. “The strength and credibility of Splash’s existing distribution network afforded us the opportunity to have a test run where the quality and consumer enthusiasm for the product drove this into a full authorization. We couldn’t be more excited, as we look forward to growing this relationship,” said Splash Beverage chair and CEO Robert Nistico in the press releases. “Our 2022 second quarter results reflect our ongoing efforts to grow the business through key distribution agreements and retail authorizations. We are exactly where we expected to be mid-year, producing another record quarter, and added six new agreements during the quarter, bringing our total number of new agreements or authorizations since our key November announcement to more than 20. We also announced our intention to acquire Pulpoloco during the quarter, an acquisition which holds potential to increase margins as well as open new channels for revenue growth as we explore the opportunities presented by its unique packaging with CartoCan.”

To view the full press releases, visit https://ibn.fm/vZVuv and https://ibn.fm/zcfbz

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and nonalcoholic beverage brands including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drinks. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, please visit www.SplashBeverageGroup.com. 

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Hero Technologies (OTCQB: HENC), a cannabis company focused on a seed-to-sale vertical integration strategy, has conducted a study of cannabis markets across the United States in order to evaluate future growth potential. According to the company, its subsidiary BlackBox Systems and Technologies LLC, has a prequalification license approval, which allows the company to produce and market cannabis for both recreational and medicinal use in Michigan. The company is anticipating launching operations in the state soon, and is also assessing opportunities in other states for both near- and medium-term growth. Specifically, the company has looked at California, Massachusetts, Colorado and Illinois, all of which have legalized both recreational and medicinal use of marijuana. The company reported that Illinois is not currently accepting cannabis license applications but plans to make 50 new licenses available later this year. The company also observed that New York, Virginia and New Jersey have moratoriums on cannabis licenses, with New York and Virginia still developing their regulatory schemes for adult-use licenses while New Jersey is allowing local municipalities some flexibility in determining licenses. The study noted that Arizona, Connecticut, Nevada, Oregon and Washington also allow recreational and medicinal use of marijuana but are not currently accepting new cannabis license applications. Overall, the study concluded that the greatest near-term opportunities for Blackbox and HENC are in Alabama and Oklahoma; Alabama is planning to accept cannabis license applications beginning Sept. 1, 2022. “As we push to establish and build our cannabis operations in Michigan for short-term growth, we are also keeping a strategic eye on the future for both near-term and medium-term opportunities,” said Hero Technologies CEO Gina Serkasevich in the press release. “Our goal is to be a multistate grower, processor and marketer of cannabis products.”

To view the full press release, visit https://ibn.fm/y4vkR

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. The company’s strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multistate operator (“MSO”). For more information about the company, please visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://ibn.fm/HENC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

PodcastOne, a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), today announced its entry into a multiyear agreement with Kevin Connolly’s boutique media network ActionPark Media (“APM”), a Los Angeles based hub specializing in podcast creation. According to the update, the deal gives PodcastOne exclusive distribution and advertising sales rights for APM’s current slate of podcast and vodcast programming. It will also allow for the two media companies to co-develop future podcast/vodcast based IP, produce advertiser sponsored live streaming and touring opportunities for hosts/talent and create exclusive licensing for podcast specific branded merchandise. “Kevin and APM clearly have a knack for producing quality podcast content with Victory the Podcast being one of the first shows giving a behind the scenes look at a hit television series and The Morning After with Kelly Stafford consistently charting as one of the top shows for parents and families,” said Kit Gray, president of PodcastOne. “This joint venture now gives us the ability to work together to grow the audience for a slate of incredible existing shows. Additionally, with LiveOne’s streaming partnerships, live event capabilities and merchandising division, we are excited to further enhance branding opportunities for the star studded roster of hosts.”

To view the full press release, visit https://ibn.fm/HWGSG

About LiveOne Inc.

Headquartered in Los Angeles, California, LiveOne is an award-winning, creator-first, music, entertainment and technology platform focused on delivering premium experiences and content worldwide through memberships and live and virtual events. The company was awarded Best Live Moment by Digiday for its “Social Gloves” PPV Event, and has been a finalist for 8 more awards, including Best Live Event, Best Virtual Event, Best Overall Social Media Excellence, and Best Original Programming from Cynopsis and Digiday . As of June 30, 2022, the company has accrued a paid and free membership base of over 2.37 million*, streamed over 2,900 artists, has a library of 30 million songs, 600 curated radio stations, over 300 podcasts/vodcasts, hundreds of pay-per-views, personalized merchandise, released music-related NFTs, and created a valuable connection between fans, brands and bands. The company’s wholly-owned subsidiaries include Slacker Radio, React Presents, Gramophone Media, Palm Beach Records, Custom Personalization Solutions, LiveXLive, PPVOne and PodcastOne, which generates more than 2.48 billion downloads per year and 300+ episodes distributed per week across its stable of top-rated podcasts. LiveOne is available on iOS, Android, Roku, Apple TV, Amazon Fire, and through OTT, STIRR, and XUMO. For more information, visit www.LiveOne.com.

*Included in the total number of paid members for the reported periods are certain members which are the subject of a contractual dispute. LiveOne is currently not recognizing revenue related to these members.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that the United States Patent and Trademark Office (“USPTO”) has granted Genprex U.S. Patent No: 11,278,592 B2. According to the update, the patent covers methods of using REQORSA(TM) Immunogene Therapy in conjunction with immune checkpoint inhibitors, through 2038. “This new patent provides critical protection for our REQORSA gene therapy in combination with a checkpoint inhibitor, for example an anti-PD1 antibody, to treat cancer. This is important as our ongoing Acclaim-2 Phase 1/2 clinical trial combines REQORSA(TM) with Keytruda(R), an anti-PD1 antibody, to treat non-small cell lung cancer,” said Thomas Gallagher, Esq., senior vice president of intellectual property and licensing at Genprex. “We continue to strengthen our intellectual property portfolio and continue to build protection around our technology as it safeguards our gene therapy with target-specific combination therapy, is a deterrent to would-be competitors and creates value around our core competencies.”

To view the full press release, visit https://ibn.fm/OVKlc

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its unique, proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic gene therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is then taken up by tumor cells that express proteins that are deficient. The company’s lead product candidate, REQORSA(TM) (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. In 2020, the U.S. Food and Drug Administration (“FDA”) granted Fast Track Designation for REQORSA for NSCLC in combination therapy with AstraZeneca’s Tagrisso(R) (osimertinib) for patients with EFGR mutations whose tumors progressed after treatment with Tagrisso. In 2021, the FDA granted Fast Track Designation for REQORSA for NSCLC in combination therapy with Merck & Co’s Keytruda(R) (pembrolizumab) for patients whose disease progressed after treatment with Keytruda. For more information, visit the company’s web site at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Amesite (NASDAQ: AMST) is the leading artificial intelligence software company offering a cloud-based platform and content creation services for business, university, non-profit, and government agency learning and upskilling. The company has announced that its founder and CEO Dr. Ann Marie Sastry will be attending Investor Summit Group’s Q3 virtual conference, which is taking place on Aug. 16-17, 2022. Dr. Sastry is scheduled to present at 11:00 a.m. ET on Aug. 17. Interested parties should visit https://ibn.fm/tRooN to register for the webinar. One-on-one meetings will be available for qualified investors, for which the conference is completely complimentary.

To view the full press release, visit https://ibn.fm/HrOT6

About Amesite Inc.

Amesite is an ed-tech, software-as-a-service (“SaaS”) company with the most advanced artificial intelligence-driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multibillion-dollar online learning markets in business and education. For more information, visit https://amesite.io.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Save Foods (NASDAQ: SVFD), an agrifood tech company specializing in ecocrop protection designed to reduce food waste and ensure food safety while reducing the use of pesticides, intends to sell shares of its common stock in a proposed public offering. According to the announcement, all of the shares of the common stock will be sold by SVFD, with ThinkEquity acting as sole book-running manager for the offering. SVFD has announced the pricing of the public offering, which will be comprised of 1,600,000 shares of common stock, at $3 per share. The company anticipates the public offering to result in $4.8 million in gross proceeds, before deducting standard underwriting discounts and offering expenses. The offering is expected to close on Aug. 18, 2022, and will be subject to customary closing conditions. In addition, the company anticipates granting the underwriters a 45-day option to purchase an additional 15% of the number of shares of common stock sold in this offering, which will cover any overallotments. The announcement noted that the offering will be subject to market conditions.

To view the full press releases, visit https://ibn.fm/bKkfc and https://ibn.fm/GT0fu

About Save Foods Inc.

Save Foods is an innovative, dynamic company addressing two of the most significant challenges in the agrifood tech industry: food waste and loss and food safety. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improve the safety and quality of life of both workers and consumers alike. SVFD’s initial applications are in post-harvest treatments in fruit and vegetable packing houses that process produce such as citrus, avocado, pears, apples and mangos. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Zomedica (NYSE American: ZOM) is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. It is Zomedica’s mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit the company’s website at www.ZOMEDICA.com.

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Nextech (CSE: NTAR) (OTCQB: NEXCF) (FSE: N29) is the engine accelerating the growth of the Metaverse. Using breakthrough AI, Nextech AR is able to quickly, easily and affordably ARitize (transform) vast quantities and varieties of existing assets at scale making products, people and places ready for interactive 3D use, giving creators at every level all the essential tools they need to build out their digital AR vision in the Metaverse. Their platform agnostic tools allow brands, educators, students, manufacturers, creators, and technologists to create immersive, interactive and the most photo-realistic 3D assets and digital environments, compose AR experiences, and publish them omnichannel. With a full suite of end-to-end AR solutions in 3D Commerce, Education, Events, and Industrial Manufacturing, Nextech AR is in a unique position to meet the needs of the world’s biggest brands and all Metaverse contributors. For more information, visit the company’s website at www.NextechAR.com.

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

American Rebel Holdings (NASDAQ: AREB, AREBW) CEO Andy Ross will present at the Investor Summit Group’s Q3 Virtual Event on August 16 at 2 pm EDT. During the presentation, Mr. Ross will highlight the company’s recently closed acquisition of Champion Safe, an acquisition which could add $20 million in revenues. Ray Crosby founded Champion Safe Company in 1999 after previously founding Fort Knox Safe in 1982 and the number one safe company today, Liberty Safe, in 1988. Liberty Safe recently sold to a middle market private investment firm for $147.5 million. Champion Safe is a leading manufacturer of gun safes, with a well-known reputation for security, fire protection, quality of finish and workmanship.

American Rebel operates primarily as a designer and marketer of branded safes and personal security and self-defense products. The company also designs and produces branded apparel and accessories. Market demand for firearms continues to surge as evidenced by the March 2021 all-time monthly record of firearm background checks since the FBI’s NICS system began in November 1998.  The home safe is becoming the new household appliance and American Rebel’s diverse product offering is well positioned to benefit from this trend. For more information, visit the company’s website at www.americanrebel.com.

The conference is completely complementary to qualified investors. Please register at https://www.meetmax.com/sched/event_85009/investor_reg_new.html?attendee_role_id=ISG_INVESTOR

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Cub Crafters (typically styled CubCrafters) is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “Yakima, Washington-based CubCrafters has spent decades appealing to those who want to fly themselves by designing, building, testing, and selling best-of-class backcountry airplanes modeled on the classic Piper PA-18 Super Cub light aircraft, and the company’s own Cub-derived newly manufactured designs. CubCrafters offers various models of aircraft that fit under FAA Certified (Part 23), Light Sport Aircraft (‘LSA’), and Experimental Amateur Built (‘E/A-B’) classifications. CubCrafters sells finished aircraft as well as aircraft kits for experimental plane enthusiasts who enjoy the hands-on, DIY emotion of assembling things themselves,” a recent article reads. “The company focuses on five main product lines – the Carbon Cub SS LSA, Carbon Cub FX EAB, Carbon Cub EX kit, the FAA-certified XCub, and the classic Top Cub… The quality and nimble performance exhibited by the original Carbon Cub made it the best-selling LSA of all time in the United States, according to the company.”

To view the full article, visit https://ibn.fm/RMwBB

About Cub Crafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to Cub Crafters are available in the company’s newsroom at https://ibn.fm/CUB

NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL AN OFFERING STATEMENT FILED BY THE COMPANY WITH THE SEC HAS BEEN QUALIFIED BY THE SEC. ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ACCEPTANCE GIVEN AFTER THE DATE OF QUALIFICATION.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has entered a further amending agreement with UEX Corporation (TSX: UEX) regarding a previously announced acquisition agreement. The previous agreement, made between UEX, UEC and UEC 2022 Acquisition Corp., has been amended on June 23, 2022, and Aug. 5, 2022, and outlines details wherein UEC will acquire all issued and outstanding common shares of UEX by way of a statutory plan of arrangement under the Canada Business Corporations Act. The announcement notes that, under the amended agreement, UEC pro forma ownership changes to 85.7%, compared to previously disclosed at 85.8% on basic share basis. According to the announcement, holders of UEX shares will now receive 0.090 of one common share of UEC for each UEX share held. The amending agreement also increases the fee paid by UEX to UEC if the transaction is terminated under certain circumstances to $9 million. The agreement also noted that UEX will accept proxies for the special meeting of UEX securityholders to approve the transaction. The company noted that the UEX board of directors has unanimously approved the amending agreement; the board also continues to recommend that UEX shareholders and holders of options and restricted share units of UEX vote in favor of the transaction.

To view the full press release, visit https://ibn.fm/rYnCv

About Uranium Energy Corp.

Uranium Energy is America’s leading, fastest-growing uranium mining company listed on the NYSE American. UEC is a pure-play uranium company and is advancing the next generation of low-cost, environmentally friendly in-situ recovery (“ISR”) mining uranium projects. The company has two production-ready, ISR hub-and-spoke platforms in South Texas and Wyoming, anchored by fully licensed and operational processing capacity at the Hobson and Irigaray processing plants. UEC also has seven U.S. ISR uranium projects with all major permits in place. Additionally, the company has other diversified holdings of uranium assets, including one of the largest physical uranium portfolios of U.S. warehoused U3O8; a major equity stake in the only royalty company in the sector, Uranium Royalty Corp; and a pipeline of resource-stage uranium projects in Arizona, Colorado, New Mexico and Paraguay. The company’s operations are managed by professionals with a recognized profile for excellence in their industry, a profile based on many decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Investor Summit Group (“ISG”), which has built a reputation for organizing some of North America’s largest and most reputable independent investor conferences, is hosting this week’s Q3 Investor Summit. The event, presented in an easy-to-use and attendee-friendly virtual format, is scheduled for Aug. 16–17, 2022; ISG presents quarterly investment summits that connect carefully curated companies and well-established management teams with qualified investors to further industry networks, explore potential synergies and forge lasting relationships. According to the announcement, the Investor Summit event series focuses on connecting leading small and micro companies with qualified individuals and entities looking to invest in the open market. The Q3 Investor Conference is designed to support companies as they participate in pivotal conversations with high-quality, long-term equity investors and industry colleagues. The event features companies from an array of sectors, including financial services, fintech, crypto, energy, healthcare, new-age materials and technology; investors attending the conference come from large marquee institutional investors and leading family offices as well as private wealth and money managers. “We are living in unprecedented economic times. With inflation raging, rates being hiked and financial markets seeing a sharp downturn, there is growing interest among investors to identify undervalued small and micro-cap companies,” said Investor Summit Group founder Fred Rockwell in the press release. “ISG’s upcoming summit is the perfect platform for young companies offering exceptional value and seasoned investors searching for high-yield plays.”

To register for the event, visit https://ibn.fm/gITLn

To view the full press release, visit https://ibn.fm/LsCmF

About the Investor Summit Group

Investor Summit Group (formerly MicroCap Conference) hosts the largest independent investor conference on the East Coast. Its independence allows conference organizers to focus on customer service and scheduling high-quality meetings between the executives and investors who attend. The ISG team sets the bar for quality service in a space traditionally dominated by banks that focus more on selling their services than on building the connections companies need to succeed. ISG has facilitated countless valuable interactions for its presenting companies, which have often led to increased exposure, market value appreciation and long-term growth. For more information about this company, visit www.InvestorSummitGroup.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, has released Q1 2023 financial results for the quarter ending June 30, 2022; the company also noted that it entered into a new note purchase agreement in May 2022 as well as receiving $5 million in proceeds. Financial highlights for the quarter include cash-operating expenses totaling approximately $1.6 million with cash and cash equivalents reach approximately $14.8 million on June 30, 2022, as compared to $17.7 million on March 31, 2022. The report also noted that additional headcount has been added to support the company’s operational scale-up process as well as focus on building product inventory to fulfill existing purchase orders and support ongoing and future commercial sales activities. “We are very pleased with the progress we are steadily making with our manufacturing and commercialization support activities,” said Nemaura Medical CEO Dr. Faz Chowdhury in the press release. “Our daily wearable continuous glucose sensor is unique and innovative, offers lifestyle advantages over competing continuous glucose sensors, and has potential applications for people with diabetes and for the consumer wearable sensor market in general. We continue to build an outstanding team of scientists, manufacturing personnel, engineers and commercial managers to help advance the company to the next phase of maturity and development. Importantly, given the current market climate, we are extremely pleased to have recently raised additional nondilutive funding without any attached warrants or options, further strengthening our balance sheet as we anticipate growing our revenues in the coming quarters.”

To view the full press release, visit https://ibn.fm/ekHrp

About Nemaura Medical Inc.

Nemaura Medical is a medical technology company developing and commercializing noninvasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT, a CE mark-approved class IIb medical device, is a noninvasive and flexible continuous glucose monitor (“CGM”) that provides actionable insights derived from real-time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse and prevent the onset of diabetes. Nemaura has submitted a premarket approval application (“PMA”) for sugarBEAT to the U.S. Food and Drug Administration (“FDA”). proBEAT combines noninvasive glucose data processed using artificial intelligence and a digital healthcare subscription service and has been launched in the United States as a general wellness product as part of NMRD’s BEAT diabetes program. Additionally, Nemaura has launched a beta trial of Miboko, a metabolic health and well-being program using a noninvasive glucose sensor along with an AI mobile application that helps a user understand how certain foods and lifestyle habits can impact one’s overall metabolic health and well-being. Nemaura believes that up to half the population could benefit from a sensor and program that monitors metabolic health and well-being. Nemaura sits at the intersection of the global type 2 diabetes market, which is expected to reach nearly $59 billion by 2025, the $50-plus billion prediabetic market and the wearable health-tech sector for weight loss and wellness applications, which is estimated to reach $60 billion by 2023. For more information about the company, visit www.NemauraMedical.com. 

NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• CubCrafters, producer of best-in-class Backcountry Aircraft, recently reported it would welcome public investment for the first time in its 42-year history 
• 48 hours after making the announcement, the company indicated that the reservations for its offering (via a Regulation A exemption) had crossed the $5 million mark, representing over 10% of the $50 million goal
• According to the company, the money raised through this public offering is set to go toward increasing production speed, improving service and support for owners of its aircraft, and accelerating innovation
• CubCrafters is eagerly anticipating qualification of the offering by the SEC, which will allow the conversion of the reservations into actual investments

Becoming a publicly-traded company was a long-standing vision of the company Founder, Jim Richmond.  Because of this, Cub Crafters (typically styled CubCrafters), a Yakima, Washington-based OEM designer and producer of backcountry aircraft has now commenced plans to materialize his vision, and is currently allowing potential investors to reserve shares in an upcoming public offering. 

The news that outside investment would be allowed for the first time in the 42 year history of the company excited potential investors, who reserved more than 1,000,000 shares of stock, worth more than $5 million (https://ibn.fm/QZ97i), in just the first 48 hours after the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to Cub Crafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, has announced that it will be rescheduling the release of its Q2 2022 financial results, which is for the period ended June 30, 2022; the company will also reschedule the earning conference call related to that report. The company anticipates releasing specific information regarding the updated release dates on or before Aug. 22, 2022; the company had previously announced that the report and conference call would both be Aug. 15, 2022. “The rescheduling is a result of ongoing company analysis and related discussions between the company and its independent registered public accountants regarding certain technical matters pertaining to the company’s revenue recognition policies related to ASC Topic 606,” the company states in the press release.

To view the full press release, visit https://ibn.fm/gEVOq  

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution and has proven effective in the treatment of an estimated 28,000 patients worldwide by more than 1,600 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nextech (CSE: NTAR) (OTCQB: NEXCF) (FSE: N29), a metaverse company and leading provider of augmented reality (“AR”) experience technologies and 3D model services, today announced its participation in the Q3 Virtual Investor Summit. Nextech AR’s CEO Evan Gappelberg is scheduled to present at 10:15 a.m. ET on Tuesday, Aug.16, 2022, when he will discuss the company’s involvement in 3D modelling for ecommerce and ARway, the disruptive spatial mapping technology for the metaverse. Interested parties should visit https://ibn.fm/6mjXj to register for the webinar. The presentation will be webcast and an archived recording will be made available in the Investors’ section of the Nextech AR website.

To view the full press release, visit https://ibn.fm/Y2GOR

About Nextech AR Solutions Corp.

Nextech is the engine accelerating the growth of the metaverse. Using breakthrough AI, Nextech AR is able to quickly, easily and affordably ARitize (transform) vast quantities and varieties of existing assets at scale making products, people and places ready for interactive 3D use, giving creators at every level all the essential tools they need to build out their digital AR vision in the metaverse. The company’s platform-agnostic tools allow brands, educators, students, manufacturers, creators, and technologists to create immersive, interactive and the most photo-realistic 3D assets and digital environments, compose AR experiences, and publish them omnichannel. With a full suite of end-to-end AR solutions in 3D commerce, education, events, and industrial manufacturing, Nextech AR is in a unique position to meet the needs of the world’s biggest brands and all metaverse contributors. For more information about the company, visit www.NextechAR.com.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that the Safety Review Committee (“SRC”) has approved continuation of the Acclaim-1 phase 1/2 clinical trial of REQORSA(TM) in combination with Tagrisso(R) (osimertinib) to treat late-stage non-small cell lung cancer (“NSCLC”) following a review of the first cohort of patients in the phase 1 portion of the trial. In 2020, Genprex received U.S. Food and Drug Administration’s (“FDA”) Fast Track Designation for treatment of the Acclaim-1 patient population. “The SRC approval to advance Acclaim-1 to the higher dose in the second cohort of patients is an important milestone that further supports REQORSA’s safety profile and brings us one step closer to bringing this potentially ground-breaking gene therapy approach to treating NSCLC to the patients who need it most,” said Mark Berger, M.D., chief medical officer of Genprex. “Enrollment in Acclaim-1 remains on track to complete the phase 1 portion of the study by year end.”

To view the full press release, visit https://ibn.fm/HJ5NI

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its unique, proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic gene therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is then taken up by tumor cells that express proteins that are deficient. The company’s lead product candidate, REQORSA(TM) (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. In 2020, the U.S. Food and Drug Administration (“FDA”) granted Fast Track Designation for REQORSA for NSCLC in combination therapy with AstraZeneca’s Tagrisso(R) (osimertinib) for patients with EFGR mutations whose tumors progressed after treatment with Tagrisso. In 2021, the FDA granted Fast Track Designation for REQORSA for NSCLC in combination therapy with Merck & Co’s Keytruda(R) (pembrolizumab) for patients whose disease progressed after treatment with Keytruda. For more information, visit the company’s web site at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting on its financial results for the second quarter 2022; the company also released a corporate and commercial update. Highlights of the report include revenue for the quarter, which totaled 6.2 million, a 17.5% increase from Q2 2021, which was $5.3 million, with six-month year-to-date revenue coming in at $14.2 million, a 60.8% increase over the same period last year. In addition, DRIO reported $55 million in total commercial contract value, noting its continued strong momentum across business-to-business-to-consumer (“B2B2C”) channels. DarioHealth also contracted with a national health plan as a strategic behavioral health partner to support 10 nearly ten million additional members, and DRIO’s strategic partnerships are increasing, a trend that the company anticipates will accelerate, resulting in increased revenue streams from employers and health plans. The company noted its improved financial profile as it completes a shift to become more B2B2C focused. “We are seeing continued contract and revenue growth with several ‘off-cycle’ employer sales, and our previously announced health plans contributing to revenue,” said DarioHealth president of North America Rick Anderson in the press release. “Our collaboration with Sanofi continues to gain traction, as the Sanofi sales organization amplifies our efforts and starts to yield health plan and other strategic opportunities. Similarly, our partnership with Solera Health is off to a strong start, with a large regional health plan in the late contracting phase, offering further evidence of the value that we can drive through our partner channels. Our pipeline is the richest it has been in the company’s history, driven by the breadth and depth of our integrated, multi-chronic condition platform. We anticipate announcing many more customers from our growing pipeline over the remainder of the year.”

To view the full press release, visit https://ibn.fm/I6bmW

About DarioHealth Corp.

DarioHealth is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market, covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario’s next-generation, AI-powered, digital therapeutic platform supports more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Dario’s unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results. The company’s cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and utilizes a performance-based approach to improve its users’ health. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Aclarion (NASDAQ: ACON, ACONW) is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain, giving physicians clarity to optimize treatment strategies. For more information, visit the company’s website at www.Aclarion.com.

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Embrace Change Acquisition Corp. (NASDAQ: EMCGU), a blank check company newly incorporated as a Cayman Islands exempted company, recently announced the pricing of its initial public offering of 6,500,000 units, each at a price of $10.00, with each unit consisting of one ordinary share, one redeemable warrant and one right. Each redeemable warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, and each right entitles the holder to acquire one-eighth of an ordinary share. The units have commenced trading on the Nasdaq Global Market under the ticker symbol EMCGU, with the IPO expected to close on Aug. 12, 2022, subject to customary conditions. Once the securities comprising the units begin separate trading, the ordinary shares, warrants and rights are expected to begin trading on the Nasdaq under the symbols EMCG, EMCGW and EMCGR, respectively. EF Hutton, division of Benchmark Investments LLC, is acting as the sole book-running manager, and US Tiger Securities Inc. is acting as the co-manager for the IPO. Embrace Change Acquisition Corp. has granted the underwriters a 45-day option to purchase up to 975,000 additional units at the IPO price to cover over-allotments, if any.

To view the full press release, visit https://ibn.fm/TeQpO

About Embrace Change Acquisition Corp.

The company is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. The company’s efforts to identify a prospective target business will not be limited to a particular business, industry, sector or geographical region, although the company will not consider or undertake a business combination with an entity or business based in, or with its principal or a majority of its business operations (either directly or through any subsidiaries) in, the People’s Republic of China (including Hong Kong and Macau), and, for the avoidance of doubt, it will not enter into an agreement for, or consummate its initial business combination with, such an entity or business, or consummate its initial business combination in circumstances where it is the counterparty to a VIE or other arrangement with a China-based entity. The company is led by its Chairman of the Board and Chief Executive Officer Yoann Delwarde and Chief Financial Officer Zheng Yuan.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage company developing drugs for patients who have unmet medical conditions that require better treatment options to improve a patient’s survival and/or quality of life, is reporting financial numbers and clinical program updates for the quarter ended June 30, 2022. Highlights of the report include news that PCSA’s PCS12852  program is on target to complete enrollment by September and that expanded efforts to increase enrollment in PCS 499 and PCS 6422 are showing results. The company also reported a cash balance on June 30, 2022, of $12.1 million, which PCSA expects to be sufficient to complete its three ongoing clinical trials and fund operations into the third quarter of 2023. “Our efforts to enhance enrollment through adding new sites, extensive marketing campaigns and working with our CRO partners are showing results,” said Processa president and CEO Dr. David Young in the press release. “We expect to close out enrollment for PCS12852 for gastroparesis within the next month and present top-line data from the trial before the end of the year. We now have a sufficient number of patients in the screening queue for PCS6422 to complete our interim cohorts, which we believe will provide valuable insights on de novo formation of DPD. We anticipate we will determine the maximum tolerated dose by early 2023. Patients are beginning to show a willingness to travel, and we are seeing increased patient activity in our PCS499 ulcerative necrobiosis lipoidica (uNL) trial. We are optimistic that we will enroll our interim analysis cohort before the end of the year. [And] as part of our efforts to increase enrollment on our PCS499 trial, we recently launched a website to increase awareness of uNL and to inform patients of the ongoing phase 2B study of PCS499. Advancing these three drugs in their respective clinical trial allows us to obtain the clinical data to better define each pivotal trial as well as provide us with more insight into how FDA will review each of these products when we submit the New Drug Applications to FDA.”

To view the full press release, visit https://ibn.fm/FQU6f

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company uses these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active clinical pipeline programs include Next Generation Capecitabine (formerly identified as PCS6422) for metastatic colorectal cancer and breast cancer program; PCS499 (“PCS499”), an ulcerative necrobiosis lipoidica program; and PCS12852 (“PCS12852”) (a GI motility/gastroparesis program). The members of the Processa development team have been involved with more than 30 drug approvals by the FDA, including drug products targeted to orphan disease conditions, and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com. 

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

AgriFORCE Growing Systems (NASDAQ: AGRI) is an AgTech company focused on the development and acquisition of crop production know-how and intellectual property augmented by advanced AgTech facilities and solutions. Looking to serve the global market, the company’s current focus is on North America, Europe and Asia. The AgriFORCE vision is to be a leader in delivering plant-based foods and products through advanced and sustainable AgTech solution platforms that make positive change in the world—from seed to table. The AgriFORCE goal: Clean. Green. Better. For more information, visit the company’s website at www.agriforcegs.com.

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Auddia (NASDAQ: AUUD) is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. Auddia offers two industry firsts-the ability to listen to any AM/FM radio station with added personalized content and no commercials, as well as podcasts with an interactive digital feed that supports deeper stories and delivers digital revenue to podcasters. Both offerings address large and rapidly growing audiences with strong purchase intent. For more information, visit the company’s website at www.Auddia.com.

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Friendable (OTC: FDBL), a mobile technology and marketing company, announced its acquisition of Artist Republik and FeaturedX in January 2022, bringing together a 360-degree suite of services for artists. The acquisition completed the company’s flagship offering, Fan Pass Live. “Artists can now sign up for the Fan Pass Live artist platform and benefit from music production, distribution and marketing services without the control of music labels pulling the strings or eating up revenue… The 360-degree suite of Fan Pass Live, Artist Republik and FeaturedX promotes being an independent label in an artist’s pocket, meaning there are no gatekeepers, no middleman, and artists retain 100% control of their music,” a recent article reads. “With our 360 offering, including Artist Republik services, FeaturedX and Fan Pass Live, each artist can continue monetizing from the fan engagement created by our promotion, further gathering more content, traffic and revenue for the company overall,” Friendable CEO Robert A. Rositano Jr. is quoted saying.

To view the full article, visit https://ibn.fm/FuoxY

About Friendable Inc.

Friendable is a mobile technology and marketing company focused on developing and identifying products, services and brand opportunities with mass market potential and scalability. Friendable published its first mobile application in the Apple App Store and Google Play Store in 2014 in the social networking and dating category. The Friendable app achieved over 1.5 million downloads, top 10 worldwide rankings, and has led to celebrity-related marketing opportunities and various relationships with well-known music artists as well as up-and-coming independent artists. Friendable has since pivoted its business focus to its music artist offering, a one-of-a-kind 360 artist platform. The offering now includes music production/collaboration, music distribution (Spotify, SoundCloud, Play Listing, livestream/live events, promotions, ticket sales, behind the scenes, merch designs/store/ship, tips, fan interaction, subscription offerings and more, which all equal revenue sharing and earning for all music artists. It is the company’s goal to become the new launch point for indie artists, as well as artists at all levels, as they build engagement, revenue and fans/followers. Launched July 24, 2020, the Fan Pass livestream platform has proven invaluable for artists and fans alike as performances shifted from the stage to the screen, with its acquisition of Artist Republik and FeaturedX in January 2022. Friendable was founded by brothers Robert A. Rositano Jr. and Dean Rositano, who have more than 27 years of experience working together on technology-related ventures. For more information, visit https://ir.Friendable.com, www.FanPassLive.com, www.ArtistRepublik.com and www.FeaturedX.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Khiron Life Sciences (OTCQX: KHRNF) is a leading vertically integrated international medical cannabis corporation with core operations in Latin America and Europe. Leveraging medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a sales presence in Colombia, Peru, Germany, United Kingdom, and Brazil and is positioned to commence sales in Mexico. The Company is led by co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors. For more information, visit the company’s website at https://investors.khiron.ca.

To view IBN’s virtual coverage of Investor Summit Group’s Q3 Virtual Event, visit  https://ibn.fm/2022InvestorSummitQ3Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Cub Crafters (typically styled CubCrafters), the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, was featured in a recent article published by the APOA Foundation. The piece highlights CubCrafters’ unveiling of its Carbon Cub EX–2 engine upgrade, as well as its plan to raise millions to speed up production and aircraft development. The article reads, “CubCrafters Vice President of Sales and Marketing Brad Damm said customers asked for a fuel-injected variant with a fixed-pitch propeller: ‘So, this is a new engine for us. Based on the previous IO-360 engine that we had. We’ve lightened it up a bunch and we’ve set it up for a fixed-pitch propeller instead of a constant-speed propeller.’ … Although there were several noticeable differences—a shorter takeoff roll, steeper climb rate and faster cruise speed—the aircraft retained the smooth, refined feel and responsiveness that Carbon Cubs are known for… ‘I think demand is going to be huge for it,’ said Damm. ‘Customers have been asking for it for a long time. We’ve had it out here all week. Lots of people have looked at it. Lots of people have been excited about it…We just can’t build airplanes quite as fast as people want to buy them.’ In addition to announcing a new Lycoming retrofit, CubCrafters also announced that as of July 25, investors can enter into a nonbinding reservation to buy shares of CubCrafters. For the first time in the company’s 40-year history, public investment will be allowed under Securities and Exchange Commission (‘SEC’) Regulation A. CubCrafters is expected to file with the SEC for qualification within weeks.”

To view the full press release, visit https://ibn.fm/tGHpa

About Cub Crafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to Cub Crafters are available in the company’s newsroom at https://ibn.fm/CUB

NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL AN OFFERING STATEMENT FILED BY THE COMPANY WITH THE SEC HAS BEEN QUALIFIED BY THE SEC. ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ACCEPTANCE GIVEN AFTER THE DATE OF QUALIFICATION.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Save Foods (NASDAQ: SVFD) (FSE: 80W) is an agri-food tech company specializing in eco crop protection that helps reduce food waste and ensure food safety while reducing the use of pesticides. The company today announced the initiation of seven commercial pilots with leading Peruvian exporters, such as Agricola Cerro Prieto (“ACP”) and another multinational packer. Under the pilots, Save Foods’ innovative treatments will be evaluated for their impact on avocados, berries and citrus fruits. “We are proud and excited to test our treatments with these companies. Our business strategy centers around countries that export to Europe and involve a long export journey, frequently consisting of thousands of miles,” said CEO of Save Foods’ Israeli subsidiary, Dan Sztybel. “Keeping produce fresh for such long journeys is likely to require the use of pesticides, which are being banned in accordance with EU’s ‘ farm to fork ’ initiative. This is where our competitive edge helps us — we can ensure businesses are EU-compliant because our treatments extend shelf life while reducing the use pesticides.”

To view the full press release, visit https://ibn.fm/AOhtW

About Save Foods Inc.

Save Foods is an innovative, dynamic company addressing two of the most significant challenges in the agri-food tech industry: food waste and loss and food safety. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improve the safety and quality of life of both workers and consumers alike. Its initial applications are in post-harvest treatments in fruit and vegetable packing houses that process produce including citrus, avocado, pears, apples and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of hazardous chemicals and their residues, Save Foods’ treatments not only prolong fresh produce shelf life and reduce food loss and waste, but they also ensure a safe, natural and healthy product. For more information, visit the company’s website at www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD   

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has presented results from its recent research showing impact of DRIO solutions to support people living in rural areas by delivering lasting health improvements. According to the presentation, the research focused on Dario’s ability to improve the health of members in rural areas, comparing results with those from urban counterparts; the results showed the solutions were equally effective. The information was presented at the Association of Diabetes Care and Education Specialists (“ADCES”) annual conference this week. In the announcement, the company noted living in rural areas is often associated with poor health, which can be aggravated by having less access to care and dealing with lower socioeconomic status. Dario’s integrated suite of chronic condition solutions helps people manage their health and care between doctors’ visits, a feature that could be highly beneficial for those living in rural areas. Dario’s research examined blood glucose data from members with high-risk type 2 diabetes living in urban areas to members living in rural areas and compared average levels of glycemic control over time; results indicated that both groups significantly reduced and maintained their average blood glucose levels, with no statistical difference between the rural and nonrural members. “Digital health represents an enormous opportunity to democratize access to better health if we build solutions that acknowledge the unique experiences of people across the country, including those outside of urban and suburban areas,” said Dario chief medical officer Omar Manejwala, MD, in the press release. “This new research shows Dario has potential to greatly improve self-care in rural populations by providing digital health tools that speak to individuals in relevant and meaningful ways no matter their location.”

To view the full press release, visit https://ibn.fm/kEy3p

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. The company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. DRIO’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Investor Summit Group (“ISG”) has partnered with InvestorBrandNetwork (“IBN”), an innovative corporate communications agency and diversified content distributor, again this year. IBN will be an official media sponsor for ISG’s virtual Q3 Virtual Summit; the event is scheduled to be held Aug. 16–17, 2022. ISG has built a reputation for its events, which facilitate collaborative partnerships between leading investors and innovative small and micro-cap companies. ISG’s upcoming Q3 Virtual Summit is designed to host cutting-edge companies and highly active qualified investors, including financial institutions, family offices, private wealth managers and seasoned money managers; during the event, investors and companies will explore technological synergies and build long-term partnerships. This year’s Q3 summit is expected to bring together nearly 70 high-quality companies and more than 600 attendees, including some of the most revolutionary corporate management teams in industries as diverse as financial services, fintech, crypto, energy, healthcare, new-age materials and technology. The summit agenda includes live presentations, informative webcasts, 1-to-1 closed-door meetings, personalized technology training and great networking opportunities. IBN has worked with ISG before to provide event corporate communications. For the Q3 Virtual Summit, IBN will work  to increase market awareness and strengthen the recognition of conference participants. “IBN will leverage its media capabilities and digital infrastructure to provide a strong virtual presence that heightens the visibility of companies participating in the upcoming virtual summit,” said IBN communications director Jonathan Keim in the press release. “We are pleased to work alongside the highly professional team at ISG once again.”

To view the full press release, visit https://ibn.fm/1NCUG

About the Investor Summit Group

The Investor Summit Group (“ISG”) is an independent company focused on providing networking opportunities to the micro-cap and small-cap communities at large. As an independent event, ISG focuses on creating a unique network of the highest-quality investors and the most valuable micro-cap and small-cap companies. ISG hosts invite-exclusive events, with each invited company being carefully selected based on strong fundamentals and growth prospects. It is an opportunity to be introduced to and speak with management at some of the most attractive companies, to ask questions to subject matter experts, and to mingle with buyside analysts and other micro-cap and small-cap investors in one-on-one meetings. For more information about this company, visit www.InvestorSummitGroup.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Helius Medical Technologies (NASDAQ: HSDT), a neurotech company focused on neurological wellness, announced the pricing of a public offering of 24,000,000 shares of its Class A common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 36,000,000 shares of its Class A common stock (“public warrants”) at a purchase price of $0.75 per share and associated public warrant. According to the update, the public warrants will have an exercise price of $0.75 per share, are exercisable upon issuance, and will expire five years following the date of issuance. Roth Capital Partners acted as lead placement agent for the offering, which closed on Aug. 9, 2022.

To view the full press release, visit https://ibn.fm/LFsKI

About Helius Medical Technologies Inc.

Helius Medical Technologies is a neurotech company focused on neurological wellness. The company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The company’s commercial product is the Portable Neuromodulation Stimulator (PoNS(TM)). For further information about the company, please visit www.HeliusMedical.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Uranium Energy (NYSE American: UEC) today announced that it has filed a Technical Report Summary (“TRS”) on EDGAR, disclosing mineral resources for its Texas hub-and-spoke in-situ recovery (“ISR”) project. “The disclosure of resources in the new S-K 1300 format at our South Texas hub-and-spoke production platform reconfirms the robust nature of the project,” said Amir Adnani, president and CEO of Uranium Energy. “Our database of drilling results, containing decades of exploration logs, shows strong potential for project expansion and also dovetails well with our initiative to increase the production license at the Hobson Plant. We are pleased with the progress of the company’s domestic ISR profile in Texas and Wyoming as we continue to advance these projects towards near term production. UEC has recently submitted an offer to the U.S. government to supply the uranium reserve (‘UR’), and we are looking forward to our production-ready projects providing future needs of the UR as well as the utility industry.”

To view the full press release, visit https://ibn.fm/fVTGH

About Uranium Energy Corp.

Uranium Energy is America’s leading, fastest growing, uranium mining company listed on the NYSE American. UEC is a pure-play uranium company and is advancing the next generation of low-cost, environmentally friendly in-situ recovery (“ISR”) mining uranium projects. The company has two production-ready ISR hub-and-spoke platforms in South Texas and Wyoming, anchored by fully licensed and operational processing capacity at the Hobson and Irigaray plants. UEC also has seven U.S. ISR uranium projects with all of their major permits in place. Additionally, the company has other diversified holdings of uranium assets, including: (1) one of the largest physical uranium portfolios of U.S. warehoused U3O8 ; (2) a major equity stake in the only royalty company in the sector, Uranium Royalty Corp.; and (3) a pipeline of resource-stage uranium projects in Arizona, Colorado, New Mexico and Paraguay. The company’s operations are managed by professionals with a recognized profile for excellence in their industry, a profile based on many decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

VistaGen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, is reporting its financial results for Q1 2023, or the period ended June 30, 2022. In addition, the company also released a corporate update for the company, noting that evaluation of its proprietary PALISADE-1 continues with interim analysis of PALISADE-2 beginning. The company also stated that preliminary data from some 200 subjects in the PALISADE open-label safety study suggests that continued use of POAI’s PH94B as needed has potential to achieve cumulative functional improvement in the severity of social anxiety disorder (“SAD”). “We remain steadfast in our commitment to change the trajectory of mental health care for millions of people affected by anxiety and depression disorders,” said VistaGen CEO Shawn Singh in the press release. “While we examine the results of our PALISADE-1 Phase 3 study in social anxiety disorder, we have paused enrollment in our PALISADE-2 Phase 3 study and have engaged an independent biostatistician to conduct an interim analysis of data collected to date. We then plan to meet with the FDA to pursue a consensus path forward for further phase 3 development of PH94B in social anxiety disorder. . . . We continue to believe in PH94B’s potential to help individuals suffering from social anxiety disorder. We are further encouraged by preliminary data from a cohort of nearly 200 patients in our PALISADE open-label safety study who have completed three months of acute, as-needed use of PH94B. These preliminary data suggest that repeated acute, as-needed use of PH94B over an extended period of time has potential to increasingly relieve symptoms of social anxiety disorder, as measured by the Liebowitz Social Anxiety Scale, or LSAS, which historically has been the diagnostic gold standard for clinical assessment of social anxiety disorder. . . . Our mission is to transform lives, and we have a strong pipeline and team in place to accomplish that goal.”

To view the full press release, visit https://ibn.fm/xU7st

About VistaGen Therapeutics Inc.

VistaGen is a late clinical-stage, CNS-focused, biopharmaceutical company striving to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than those that are currently available. VistaGen’s clinical-stage candidates are targeting multiple forms of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are odorless and tasteless investigational neuroactive steroids designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. VistaGen is passionate about transforming mental-health care and redefining what is possible in the treatment of anxiety and depression. For more information about the company, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is reporting its numbers for second quarter 2022, or the period ended June 30, 2022. According to the announcement, the report indicates a strong balance sheet with a solid cash balance, commensurate equity and no debt. Highlights from the quarter include the commercialization launch of PeDAL, POAI’s innovative AI product, along with the company’s presence at BIO International, which included one-on-one partnering meetings with pharmaceutical and biotech companies; the appointment of Julia Kirshner, PhD, as chief scientific officer; the consolidation and expansion of POAI’s research and development team with TumorGenesis moving to Pittsburg; and a 12% increase of cash and equivalents from $25 million on March 31, 2022, to $28 million at quarter end. Other financial numbers for the quarter include net sales revenue of $0.4 million for the quarter, an increase of 6% from the same three-month period in 2021; gross profit margin for the company growing from 59% in Q2 2021 to 64% for Q2 2022; net cash used in operating activities totaling $6.4 million for the six months ended June 30, 2022; and general and administrative expenses totaling $2.4 million, up from $2.1 million in the quarter ended June 30, 2021. In addition, POAI’s quarterly sales and marketing expenses increased to $0.3 million for the quarter, up by $0.1 million from the same quarter in 2021. The company also announced a shareholder earnings webcast to be held Friday, Aug. 12, 2022, at 12 p.m. ET.

To view the full webcast, visit https://ibn.fm/CLjK7

To view the full press release, visit https://ibn.fm/UgEac

About Predictive Oncology Inc.

Predictive Oncology is a knowledge-driven company, applying artificial intelligence to develop personalized cancer therapies that improve patient outcomes. The company, which offers a suite of solutions for oncology drug development, operates through four segments (Skyline, Helomics, zPREDICTA and Soluble), which covers five subsidiaries: Helomics, zPREDICTA, Soluble Biotech, TumorGenesis and Skyline Medical. Helomics Holding Corporation is involved in applying artificial intelligence (“AI”) in the company’s precision medicine business, to offer AI-driven predictive models of tumor drug response to enhance clinical results for patients and to aid diagnostic, biotech and pharmaceutical companies in new personalized diagnostic and drug development. Skyline Medical Inc. sells the STREAMWAY System(R), a fully automated wall-mounted product that is utilized to dispose of an unlimited quantity of suction fluid in an operating room setting. It offers continuous performance for medical practitioners by effectively eradicating the healthcare professional’s exposure to potentially infectious liquids gathered during surgical and other medical operations. Soluble Biotech Inc. is involved in research and commercialization focused on protein production, stability studies and solubility improvements. zPREDICTA Inc. does tumor-specific research using in vitro models for oncology and drug development. TumorGenesis serves as the company’s arm for research and development for zPREDICTA, Soluble and Helomics. This subsidiary is also involved in cellular media kit production, which aids cancer cells to grow outside the body of patients while preserving their proteomic and RNA/DNA signatures. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Sustain Southern California (“Sustain SoCal”) today announced that it will host the Water Solutions 7 (“WS7″) Conference on Thursday, Aug. 25, 2022. The premier event, to be held in person at UCI Beall Applied Innovation in Irvine, will focus on real-life strategies and cutting-edge innovation to ensure sufficient and affordable water supplies in Southern California and the surrounding regions. “The Water Solutions event series is now in its 7th iteration. It has consistently offered an exciting platform for students, professionals and the general public, whose support we appreciate very much,” said Scott Kitcher, president and CEO of Sustain SoCal. “At Sustain SoCal, we are dedicated to contributing to the sustainability and economic discourse in the Southern California region and beyond. By being strategically located at UCI Beall Applied Innovation, we have been privileged to enable collaboration between world-class university resources and industry professionals in the water supply and allied sectors for more than a decade.”

To view the full press release, visit https://ibn.fm/wqsZA

About Sustain SoCal

Sustain SoCal, a non-profit organization, accelerates sustainability and economic growth through innovation, collaboration and education in Southern California. The organization has a ten-year history in exploring and implementing pragmatic, real-world solutions to the challenges created by growth, change and inefficiency. It conducts conferences, workshops and networking events that lead to initiatives that positively impact the region’s economic progress and sustainability. For more information, please visit www.SustainSoCal.org.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

SPYR (OTCQB: SPYR), a diversified technology company developing products and leveraging the Internet of Things (“Iot”) for consumer use and large-scale applications and industries, and its subsidiary GeoTraq, were mentioned in a recent Emerging Markets Report. The report noted that SPYR focus is developing, marketing and positioning the GeoTraq small transmitter tracking devices, including the company’s newest offering, the Micro-Tracker(R), as the leading edge of IoT asset tracking technology. The announcement noted that these proprietary tracking devices can be used to monitor and track everything from Porta-Potties at major music festivals to locating construction assets at a job site; the devices are also designed to mission-critical information about valuable supply chain assets monitoring temperature, flow, pressure, humidity, motion, acceleration and more. The report also noted that SPYR’s ambitions are not limited to its goals to market and sell the GeoTraq Micro-Tracker, which includes rolling out the device in Q1 or Q2 2023. “SPYR’S plans include the development and deployment of its Micro-Tracker, the next generations of GeoTraq’s tracking tech,” the report stated. “SPYR is upgrading its communication technology to a state-of-the-art cell location technology that will provide Micro-Tracker customers with two advantages: First, the new technology will provide a significant improvement in position accuracy of the device and the asset it tracks. . . . Just as important as location accuracy, the Micro-Tracker technology has a much faster position acquisition time.”

To view the full press release, visit https://ibn.fm/IHcXq

About SPYR Inc.

SPYR Technologies is a technology company that, through its subsidiary Applied Magix Inc., develops and resells Apple(R) ecosystem-compatible products with an emphasis on the growing multibillion-dollar IoT smart-home and connected-car markets. Through its GeoTraq business, SPYR develops and manufactures entirely self-contained, ultra-small mobile Internet of Things (“IoT”) modules including Trackertracker-M modules for asset tracking and location-based services and Sensorsensor-M modules used for remote monitoring. SPYR continues to identify and target acquisitions that will grow its footprint in the industry and expand the products it offers consumers, including companies developing artificial intelligence (“AI”) and smart-technology products. For more information about this company, visit https://ir.spyr.com.

NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biopharmaceuticals and other industries. The company today announced approval for its South Easton, Massachusetts, facility to manufacture custom, compliant, hemp-derived CBD nanoemulsions under the processing/manufacturing license of its commercial partner, Canopy CBD Farms (“CCF”). CFF is a Massachusetts-licensed hemp processing and manufacturing company. “I am delighted to partner with PBI by extending my CBD processing and manufacturing license to PBI’s South Easton location,” said John Westlake, founder and president of CCF. “I firmly believe I can leverage my many years in the cannabis market and hundreds of industry connections to help PBI get quickly and efficiently to market with their unique, highly stable and water-soluble hemp-derived CBD nanoemulsions, processed using their world-class UST platform.”

To view the full press release, visit https://ibn.fm/r0Pjd

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). The company’s primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) recently acquired, patented technology from BaroFold Inc. (the BaroFold technology) to allow entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a propriety SaaS technology company delivering “state-of-the-art” mobile live dealer technology and eTable games to online gaming operators globally, announced that it is working with independent testing laboratory Gaming Laboratories International(R) (“GLI”). According to the company, GLI provides world-class testing, certification and professional services to the global gaming industry’s suppliers, regulators and operators across more than 480 jurisdictions. According to the announcement, the company successfully received certification for live dealer studio in accordance with GLI-19, Isle of Man and Ontario technical requirements, thereby better positioning the company for pending commercial agreements licensed in those jurisdictions. The company explained that it partnered with GLI to complete GLI-19 Interactive Gaming Systems testing and audit requirements for its Las-Vegas-based live dealer studio as well as to evaluate Playgon’s technology with requirements from additional jurisdictions that will be driven by commercial customer agreements. The company noted that additional jurisdictions will be completed over time and in stages as future customer launches occur. “Adding Ontario and Isle of Man certifications and continuing to work with GLI to certify other jurisdictions further strengthens our global footprint and strategy,” said Playgon Games CEO Darcy Krogh in the press release.

To view the full press release, visit https://ibn.fm/8qpHu

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, Playgon products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups and big database companies. For more information about the company, please visit www.Playgon.com. 

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

iClick (NASDAQ: ICLK) is a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions. The company today announced that it will report its unaudited second quarter 2022 financial results before the U.S. market opens on Thursday, Aug. 25, 2022. Jian “T.J.” Tang, iClick’s chairman, chief executive officer and co-founder, and David Zhang, chief financial officer, will host a conference call to discuss the company’s business and financial performance at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on Aug. 25. Interested parties may join the call by pre-registering at https://ibn.fm/LFzj8 and utilizing the dial-in numbers, passcode and unique access PIN that will be provided upon registration. Participants may also visit https://ibn.fm/biBVc to join a live and archived webcast of the call.

To view the full press release, visit https://ibn.fm/dgTyG

About iClick Interactive Asia Group Limited

Founded in 2009, iClick is a leading enterprise and marketing cloud platform in China. iClick’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a national health plan selected its solution to drive self-service across its mental wellbeing care resources. According to the update, Dario’s behavioral health solution will become part of the plan’s platform to increase access to navigation, self-help and coaching. “We are thrilled to collaborate with the plan to provide a more consumer-friendly, digital and seamless experience for users. Our ability to connect people quickly and conveniently to the right care for their needs with proven, evidence-based tools will make it easier for members to achieve better health,” said Rick Anderson, president of Dario. “We expect to reach close to ten million members with access to Dario’s behavioral health solution over the next couple of years. The agreement between the plan and Dario is expected to begin generating potential revenue in the third quarter of 2022 with broad-based roll out anticipated to commence in 2023.”

To view the full press release, visit https://ibn.fm/wIgof

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results. Making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.